The aim of this study was to compare the quality of life (QoL) and the prevalence of depression and anxiety in patients with type 2 diabetes mellitus according to the type of treatment: insulin, oral therapy or both therapies. A cross-sectional study that included adults with diabetes mellitus type 2 was conducted at Hassan II University Hospital in Fez, Morocco. Patients are divided into 3 groups: the anti-diabetic agents’ group, the insulin therapy group and the combined therapy group. The Hospital Anxiety and Depression Scale (HADS) was used to measure depression and anxiety. A 12-Item Short-Form Health Survey questionnaire (SF-12) was employed to assess QoL. All statistical analyses were conducted using SPSS Version 26. A total of 176 diabetics with type 2 were included in the study: (61.9%) in the hypoglycemic drug group; (14.2%) in the insulin group and (23.9%) in both therapy groups. The mean age of the patients was 54.36 ± 10.18 years with a female predominance (60.8%). Our study showed a significant association between the scores of QoL (p < 0.05), the prevalence of depression (p = 0.03) and the type of therapy. A high prevalence of depression and poor QoL have been observed in patients on insulin therapy. Patients on insulin therapy have a high prevalence of depression and a more significant impairment of QoL. In fact, their evaluation must be integrated into the management of type 2 diabetics on insulin.
Cite this paper
Benmaamar, S. , Salhi, H. , Harch, I. E. , Lazar, N. , Diagne, B. J. , Maiouak, M. , Berraho, M. , Tachfouti, N. , Ouahabi, H. E. and Fakir, S. E. (2023). Comparison of Quality of Life, Depression and Anxiety According to the Type of Treatment in Type 2 Diabetes. Open Access Library Journal, 10, e062. doi: http://dx.doi.org/10.4236/oalib.1110062.
Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843.
https://doi.org/10.1016/j.diabres.2019.107843
Khan, M.A.B., Hashim, M.J., King, J.K., Govender, R.D., Mustafa, H. and Al Kaabi, J. (2019) Epidemiology of Type 2 Diabetes—Global Burden of Disease and Forecasted Trends. Journal of Epidemiology and Global Health, 10, 107-111.
https://doi.org/10.2991/jegh.k.191028.001
Bickett, A. and Tapp, H. (2016) Anxiety and Diabetes: Innovative Approaches to Management in Primary Care. Experimental Biology and Medicine (Maywood), 241, 1724-1731. https://doi.org/10.1177/1535370216657613
Roy, T. and Lloyd, C.E. (2012) Epidemiology of Depression and Diabetes: A Systematic Review. Journal of Affective Disorders, 142, S8-S21.
https://doi.org/10.1016/S0165-0327(12)70004-6
Jing, X., Chen, J., Dong, Y., et al. (2018) Related Factors of Quality of Life of Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis. Health and Quality of Life Outcomes, 16, 189. https://doi.org/10.1186/s12955-018-1021-9
Shetty, A., Afroz, A., Ali, L., Siddiquea, B.N., Sumanta, M. and Billah, B. (2021) Health-Related Quality of Life among People with Type 2 Diabetes Mellitus—A Multicentre Study in Bangladesh. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15, Article ID: 102255.
https://doi.org/10.1016/j.dsx.2021.102255
Chung, J.O., Cho, D.H., Chung, D.J. and Chung, M.Y. (2013) Assessment of Factors Associated with the Quality of Life in Korean Type 2 Diabetic Patients. Internal Medicine, 52, 179-185. https://doi.org/10.2169/internalmedicine.52.7513
Cong, J.-Y., Zhao, Y., Xu, Q.-Y., et al. (2012) Health-Related Quality of Life among Tianjin Chinese Patients with Type 2 Diabetes: A Cross-Sectional Survey. Nursing & Health Sciences, 14, 528-534. https://doi.org/10.1111/j.1442-2018.2012.00734.x
Marín-Peñalver, J.J., Martín-Timón, I., Sevillano-Collantes, C. and Cañizo-Gómez, F.J. (2016) Del: Update on the Treatment of Type 2 Diabetes Mellitus. World Journal of Diabetes, 7, 354. https://doi.org/10.4239/wjd.v7.i17.354
Bai, X., Liu, Z., Li, Z. and Yan, D. (2018) The Association between Insulin Therapy and Depression in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis. BMJ Open, 8, e020062. https://doi.org/10.1136/bmjopen-2017-020062
Surkiene, G. (2014) Prevalence and Determinants of Anxiety and Depression Symptoms in Patients with Type 2 Diabetes in Lithuania. Medical Science Monitor, 20, 182-190. https://doi.org/10.12659/MSM.890019
Pouwer, F. and Hermanns, N. (2009) Insulin Therapy and Quality of Life. A Review. Diabetes/Metabolism Research and Reviews, 25, S4-S10.
https://doi.org/10.1002/dmrr.981
Obtel, M., El Rhazi, K., Elhold, S., Benjelloune, M., Gnatiuc, L. and Nejjari, C. (2013) Cross-Cultural Adaptation of the 12-Item Short-Form Survey Instrument in a Moroccan Representative Survey. Southern African Journal of Epidemiology and Infection, 28, 166-171. https://doi.org/10.1080/10158782.2013.11441540
Ware, J.E., Kosinski, M. and Keller, S.D. (1996) A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Medical Care, 34, 220-233. https://doi.org/10.1097/00005650-199603000-00003
Bensbaa, S., Agerd, L., Boujraf, S., et al. (2014) Clinical Assessment of Depression and Type 2 Diabetes in Morocco: Economical and Social Components. Journal of Neurosciences in Rural Practice, 5, 250-253.
https://doi.org/10.4103/0976-3147.133576
Polonsky, W.H., Hajos, T.R.S., Dain, M.-P. and Snoek, F.J. (2011) Are Patients with Type 2 Diabetes Reluctant to Start Insulin Therapy? An Examination of the Scope and Underpinnings of Psychological Insulin Resistance in a Large, International Population. Current Medical Research and Opinion, 27, 1169-1174.
https://doi.org/10.1185/03007995.2011.573623
Réticences à l’insulinothérapie du patient diabétique de type 2: Croyances du soigné et du soignant.
https://www.realites-cardiologiques.com/wp-content/uploads/sites/2/2011/10/Ciangura.pdf
Skinner, T.C., Carey, M.E., Cradock, S., et al. (2010) Depressive Symptoms in the First Year from Diagnosis of Type 2 Diabetes: Results from the Desmond Trial. Diabetic Medicine, 27, 965-967. https://doi.org/10.1111/j.1464-5491.2010.03028.x
Palizgir, M., Bakhtiari, M. and Esteghamati, A. (2013) Association of Depression and Anxiety with Diabetes Mellitus Type 2 Concerning Some Sociological Factors. Iranian Red Crescent Medical Journal, 15, 644-648.
https://doi.org/10.5812/ircmj.12107
Trento, M., Raballo, M., Trevisan, M., et al. (2012) A Cross-Sectional Survey of Depression, Anxiety, and Cognitive Function in Patients with Type 2 Diabetes. Acta Diabetologica, 49, 199-203. https://doi.org/10.1007/s00592-011-0275-z
Reis, A.C., Cunha, M.V., Bianchin, M.A., Freitas, M.T.R., Castiglioni, L., et al. (2020) Comparison of Quality of Life and Functionality in Type 2 Diabetics with and without Insulin. Revista da Associacao Medica Brasileira, 65, 1464-1469.
https://doi.org/10.1590/1806-9282.65.12.1464
Redekop, W.K., Koopmanschap, M.A., Stolk, R.P., et al. (2002) Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients with Type 2 Diabetes. Diabetes Care, 25, 458-463. https://doi.org/10.2337/diacare.25.3.458
Chantelau, E., Schiffers, T., Schütze, J. and Hansen, B. (1997) Effect of Patient-Selected Intensive Insulin Therapy on Quality of Life. Patient Education and Counseling, 30, 167-173. https://doi.org/10.1016/S0738-3991(96)00964-0
U.K. Prospective Diabetes Study Group (1999) Quality of Life in Type 2 Diabetic Patients Is Affected by Complications but Not by Intensive Policies to Improve Blood Glucose or Blood Pressure Control (UKPDS 37). Diabetes Care, 22, 1125-1136. https://doi.org/10.2337/diacare.22.7.1125
